WASHINGTON – President Donald Trump says he’ll signal an govt order on Monday that, if applied, might deliver down the prices of some drugs — reviving a failed effort from his first time period on a difficulty he is talked up since even earlier than changing into president.
The order Trump is promising will direct the U.S. Division of Well being and Human Companies to tie what Medicare pays for drugs administrated in a physician’s workplace to the bottom worth paid by different international locations.
“I will probably be instituting a MOST FAVORED NATION’S POLICY whereby america can pay the identical worth because the Nation that pays the bottom worth wherever within the World,” the president posted Sunday on his social media website, pledging to signal the order on Monday morning on the White Home.
“Our Nation will lastly be handled pretty, and our residents Healthcare Prices will probably be decreased by numbers by no means even considered earlier than,” Trump added.
His proposal would probably solely impression sure medicine lined by Medicare and given in an workplace — assume infusions that deal with most cancers, and different injectables. Nevertheless it might doubtlessly deliver important financial savings to the federal government, though the “TRILLIONS OF DOLLARS” Trump boasted about in his submit could also be an exaggeration.
Medicare offers medical health insurance for roughly 70 million older People. Complaints about U.S. drug costs being notoriously excessive, even compared with different giant and rich international locations, have lengthy drawn the ire of each events, however a long-lasting repair has by no means cleared Congress.
Underneath the deliberate order, the federal authorities would tie what it pays pharmaceutical firms for these medicine to the worth paid by a bunch of different, economically superior international locations — the so-called “most favored nation” strategy.
The proposal will face fierce opposition from the pharmaceutical trade.
It was a rule that Trump tried to undertake throughout his first time period, however might by no means get by. He signed an identical govt order within the remaining weeks of his presidency, however a court order later blocked the rule from going into impact below the Biden administration.
The pharmaceutical trade argued that Trump’s 2020 try would give international governments the “higher hand” in deciding the worth of medicines within the U.S.. The trade has lengthy argued that forcing decrease costs will damage earnings, and in the end have an effect on innovation and its efforts to develop new medicines.
Solely medicine on Medicare Half B — the insurance coverage for physician’s workplace visits — are more likely to be lined below the plan. Medicare beneficiaries are liable for selecting up a few of the prices to get these drugs throughout physician’s visits, and for conventional Medicare enrollees there isn’t a annual out-of-pocket cap on what they pay.
A report by the Trump administration throughout its first time period discovered that the U.S. spends twice as a lot as another international locations in masking these medicine. Medicare Half B drug spending topped $33 billion in 2021.
Extra widespread pharmaceuticals stuffed at a pharmacy would most likely not be lined by the brand new order.
Trump’s submit formally previewing the motion got here after he teased a “very huge announcement” final week. He gave no particulars, besides to notice that it wasn’t associated to commerce or the tariffs he has introduced imposing on a lot of the world.
“We’re going to have a really, very huge announcement to make — like as huge because it will get,” Trump mentioned final week.
He got here into his first time period accusing pharmaceutical firms of “getting away with homicide” and complaining that different international locations whose governments set drug costs have been profiting from People.
On Sunday, Trump took purpose on the trade once more, writing that the “Pharmaceutical/Drug Firms would say, for years, that it was Analysis and Growth Prices, and that every one of those prices have been, and could be, for no purpose in any way, borne by the ‘suckers’ of America, ALONE.”
Referring to drug firms’ highly effective lobbying efforts, he mentioned that marketing campaign contributions “can do wonders, however not with me, and never with the Republican Celebration.”
“We’re going to do the proper factor,” he wrote.
Copyright 2025 The Related Press. All rights reserved. This materials will not be printed, broadcast, rewritten or redistributed with out permission.
